fda warning letters compounded tirzepatide 2024 2025 issued 25 to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Tirzepatide and Macular Degeneration: Current
Description
This data helps you and your provider make informed decisions about dose adjustments
We monitor your lipase levels and renal function through regular blood work to ensure your treatment remains safe and effective for your specific physiology
And body recomposition, including muscle preservation and fat loss, doesn't always register on the scale even when it's happening
It is not uncommon for patients using tirzepatide for weight loss to lose 10 to 15% or more of their starting body weight over a year of usage
